Pregled bibliografske jedinice broj: 589911
Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells
Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells // Pharmacological research, 66 (2012), 4; 357-362 doi:10.1016/j.phrs.2012.06.011 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 589911 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells
Autori
Banjanac, Mihailo ; Munić Kos, Vesna ; Nujić, Krunoslav ; Vrančić, Mila ; Belamarić, Daniela ; Crnković, Slaven ; Hlevnjak, Mario ; Eraković Haber, Vesna
Izvornik
Pharmacological research (1043-6618) 66
(2012), 4;
357-362
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
azithromycin; inflammation; J774A.1 cells; LPS; cytosolic phospholipase A2
Sažetak
Azithromycin is a macrolide antibiotic with well-described anti-inflammatory properties which can be attributed, at least partially, to its action on macrophages. We have previously shown, with 18 different macrolide molecules, that IL-6 and PGE2 inhibition correlates with macrolide accumulation, as well as with their binding to phospholipids in J774A.1 cells. The present study was performed in order to substantiate the hypothesis that biological membranes are a target for macrolide anti-inflammatory activity. By analyzing the effect of azithromycin on overall eicosanoid production, we found that in LPS-stimulated J774A.1 cells, azithromycin, like indomethacin, inhibited the synthesis of all eicosanoids produced downstream of COX. Upstream of COX, azithromycin inhibited arachidonic acid release in the same way as a cPLA2 inhibitor, while indomethacin had no effect. Further comparison revealed that in LPS-stimulated J774A.1 cells, the cPLA2 inhibitor showed the same profile of inhibition as azithromycin in inhibiting PGE2, IL-6, IL-12p40 and arachidonic acid release. Therefore, we propose that the anti-inflammatory activity of azithromycin in this model may be due to interactions with cPLA2, causing inadequate translocation of the enzyme or disturbing physical interactions with its substrates.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Fidelta d.o.o.
Profili:
Krunoslav Nujić
(autor)
Mila Vrančić
(autor)
Daniela Belamarić
(autor)
Vesna Munić Kos
(autor)
Vesna Eraković Haber
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE